Safe Chemotherapy Option for Children Battling Sickle Cell Disease

A groundbreaking study indicates that hydroxyurea, an oral chemotherapy drug, effectively manages sickle cell disease in children. Research published in Blood Advances reveals that kids on hydroxyurea had fewer emergency room visits and hospital days. Dr. Paul George emphasizes its enduring benefits, affirming hydroxyurea's safety and efficacy, especially for pediatric patients. The study tracked over 2,140 children, noting significant reductions in pain crises among those consistently using the medication. Hydroxyurea's status as a trusted treatment continues, providing reassurance for families affected by sickle cell disease.